<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 283 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page282.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=283">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 283 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 283</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=283"><img src="../thumb/283.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>246 / 2020-04                                                    Anti-Microbials - 18.8.1 / 18.8.2 / 18.9
                                                                              nd
   Contraindications: Hypersens.to ethionamide/ pyrazinamide/nia-  haematocr., incr.platelet/WBC counts, insomn., headache, metal.  Dosage: Admin. once dly. IV or IM. A 2  inj.to be admin.on first day
   cin, safety in pregn.& lactat.not est.  taste, diarrh., naus., vomit., constip., abdom.pain/cramps/ distens.,   in sev. infects. Admin.IV as bolus dos. or infus. over 30 min. Do not ad-
   Side effects: GI disturbs.incl.pellagra, hypersens. reacts, skin rash.  fev., incr.bilirub./AST/ALT/LDH/alkaline phosphat./ bld.urea/creat.  min.for long. than 4 mnths. Endocardit.& osteomyelit: 3 wks. treatm.
   incl.pellagra-like dermatit., bld. dyscras.incl.aplast.anaem., neurolog.  kinase/lipase/amylase/ non-fast.gluc., decr.total prot./album./Na/   or long.recomm. Result usual.with. 48-72 hrs. Ther.durat.determ.by
   effs.incl. psychot. reacts., convuls., hyperglycaem., metabol. acidos.,   Ca., incr. or decr.potass./bicarb. Less freq: Eosinophil./ neutropen,   type & sev.of infect. & clinic.respons. Contin. for at least 3 days aft.
   lupus-like/ rheumatoid syndr., urin.retent., gynaecomast., optic neu-  incr.reticuloc.count, decr. neutrophils, hypersens.reacts., bull.skin   pt.afebr. & clinic.sympt.disapp.
   rit., periph.neuropathy.     erupts. incl.Stev.-Johns.syndr., lact.acidos., incr.ser.creat. phospho-  Adults incl.elderly:
   Special precautions: Cons.benef.-risk ratio in alcohol./liv.& ren.  kin., hyperglycaem., hypaesthes., paraesthes., periph.neuropathy,   Mod.infects: UTI, skin & soft tiss.infects: Load. dos: 400 mg as sngl.
   funct.impairm/convuls.disords./ psychos.hist., pts.at risk of neu-  convuls., seroton. syndr., optic neuropathy, blurr.vis., loss of vis., vis.   IV inj.on 1st day. Maint: 200 mg sngl.dly.IV/IM.
   ropathy/pyridoxine defic., prophylact.pyridoxine 100-200 mg dly.   field defect, change in col.vis., tinnit., dizzin., hyper-/hypotens., dry   Sev.infects: Endocardit, septicaem., joint & bone infects:
   recomm. for periph.neurit.counteract., diabet., malnourish., uraem.,   mouth, dyspeps., gastrit., incr. thirst, pancreatit., tongue/ teeth dis-  Load.dos: 400 mg IV 12 hrly.for first 3 dos. Maint: 400 mg sngl.dly.
   pregn., porphyr., admin.Al-contain.antacids at least 1 hr aft.treatm.,   colour., dermatit., diaphores., prurit., rash, urticar., polyur., vulvovagin.   IV/IM. Dos.of up to 12 mg/kg may be reqd. Adapt.in overweight pts.
   hepatotoxic., LFT to be done 3 mnthly. dur.treatm., discont. treatm.  disord., vaginit., fatig., chills, phlebit./ thrombophlebit., loc.pain, incr.  Prophylax.in orthopaed.& vasc.surg: 400 mg as sngl.IV inj.at
   if sev.incr.in hepat.enzyme lev.even if no sympt., incr.hepatit.risk in   creatin./Na./Ca, decr. non-fast.gluc., incr./decr.Cl  induct.of anaesthes.
   pts.&gt;50 yrs./slow acetylators/dly.alcoh.consumpt., poss.itch./ tachy-  Warnings and special precautions: Discont. treatm. in pts.  Childr.from 3 yrs:
   card./ chills/headache with cert.chees./fish.  exper.signif.myelosupress., full bld counts recomm.in pres.of my-  Sev.infects: 10 mg/kg 12 hrly by IVI for 3 dos.then 10 mg/kg IV/
   Drug interactions: Decr.plasma clear.&/prolong. act.durat.of alfen-  elosuppress./other concom. med.caus.bone marr.suppress./ chron.   IM as sngl.dly.dos.
   tanil/coumarin anticoags./ benzodiazep./ carbamazepin./phenytoin/  infects./concurr.antibiot.treatm., not stud.in treat. decubit.ulc., poss.  Mod.infects: 10 mg/kg 12 hrly by IVI for 1  3 dos. thereaft. 6 mg/
                                                                                st
   theophyll., poss.incr.isoniazid-induc.hepatotox.with paracetamol/ al-  lact.acidos., poss mitochondr. dysfunct.in ther.&gt;28 days, monit.vis.  kg IV/IM as sngl.dly.dos.
   coh./rifampicin & other hepatotox. meds., poss.delay.& decreas.ab-  funct.reg.in ther. &gt;28 days, compare risk.vs.benef.of ther.in pts. de-  CAPD: Sngl.IV load.dos.of 400 mg, then 20 mg/L bag in 1  wk, 20 mg/L/
                                                                                    st
   sorpt.& ser.conc. with Al-contain.antacids, poss. incr.hepat.metabol.   velop. optic./ periph.neuropathy/lact. acidos., seiz.hist./seiz.risk fac-  alt.bags in 2  wk & 20 mg/L in overnight dwell bag only in 3  wk.
                                                                                      rd
                                                                   nd
   &/ isoniazid excret.with glucocortic.corticoster., incr. CNS toxic.potent.  tors, porphyr., avoid tyramine-rich food, imp.ren./hepat.funct., antibiot.   Contraindications: Safety & effic.in childr.und. 3 yrs./pregn.& lactat.
   with cycloserine/disulfiram & other neurotox.meds., poss.incr.format.  assoc. diarrh./colit.incl.pseudomembr.colit., meds. inhibit.gut motil./  not est., subarachnoid space inj., mix.with aminoglycosid.in same sol.
   of potent. nephrotox. inorgan.fluoride metabolit.with enflurane, inter-  peristals.when antibiot.assoc. diarrh./colit suspect., superinfect., de-  Side effects: Trombocytopen., GI disturbs., skin reacts.incl.exfoll.
   acts.with ketoconazole/miconazole.  term.suscept. bef. init.ther., consid.alt.bef.init.ther.as outpt., safety   dermatit./ Stev.-Johns.syndr./tox. epiderm. necrolys., bronchosp.,
                                & effic.of ther.long.than 28 days not est., observ. closely for S&S of   hear.loss, tinnit./ vestibul. disturbs., ren.impairm., fev., anaphylax.,
                                seroton.syndr.where admin. with clin.appropr.concom.serotonerg.   angioed., dizzin., tiss.necros., headache, bld. dyscras., inj. site reacts.,
   18.8.2  Anti-leprotics       agents, not stud.in uncontrol.hypertens./ phaeochromocyt., untreat.  flush., Red Man Syndr., superinfect.
                                hyperthyroid., poss. interact. with sympathomimet./adrenerg.agents,
                                admin. aft.haemodialys., lact.intol.  Special precautions: Vancomycin-cross-sens., monit.ren.impairm.,
                                                              period.haematolog./liv./ren. funct. monit.advis.dur.prolong.treatm.,
   A-LENNON DAPSONE, (Aspen Pharmacare: Pharma)   Interactions: Mild revers.enhancem.of press. respons. induc.by   monit.ren.& audit. funct.with other concom.ototox./nephrotox. meds.,
   Pharmacare [P/S]             pseudoephedr.& phenylpropanolamine HCl & dos.of compds incl.   eval.dur.superinfect.
   Dapsone.                     dopamine/ adrenaline should be reduc, potent. signif. press.re-
   Indications: All types leprosy, of value in dermatit. herpetiform.,   spons.with concom.tyramine contain. food., seroton.syndr.with con-  CLINDAHEXAL 150, Sandoz [P/S]
   toxoplasmos. & mycetoma, suppress. act.on malar.plasmodia.  com. serotonerg. agents incl.SSRIs, poss.coma/resp. depress. with   Clindamycin HCl equiv.to clindamycin.
   (S4) TABS. J/20.2.4/431.     concom.opiod analges., decr.expos. with meds induc.hepat.enzym.  Indications: Ser.U&LRTI, skin & soft tiss.infects., dent. infects., ac./
   717460-002: 100 mg, 100, R299,95  ASPEN VANCOMYCIN CP, (Aspen Pharmacare: Pharma)   chron.osteomyelit.& bacteraem. caus.by suscept.organ.
   Dosage: Import.not to miss dose and take at same time each day.  (S4) CAPS, 32/20.1.1/0038
   Leprosy: In combinat.with other antileprosy agents. Adults:. 50-  Pharmacare [P/S]  849960-002: 150 mg, 20, R98,39
   100 mg or 1,4 mg/kg bm once dly. Paed.& low weight pts: 1,4 mg/  Vancomycin HCl equiv.to vancomycin.  849960-010: 150 mg, 100, R492,47
   kg bm once dly.              Indications: Methicill.-resist. (β-lactam-resist) staphylococ.infects.,   Dosage: Admin.6 hrly.with meals.
   Dermatit.herpetiform: Adults: Init. 50 dly.incr.grad.to 300 mg dly.   ser.staphylococ.infects.in penicill. allerg.pts./pts.who fail to respond   Adults: Mild to mod. sev.infect: 150 mg. Sev.infect: 300-450 mg.
   Or more if reqd. If high.dos.employ.reduc.to min.maint.dos.ASAP.   to penicill./ cephalosporin & ser.vancomycin suscept. organ. infects.  Contraindications: Lincomycin sens., safety in pregn.& lactat.not
   Paed.& low weight pts: Init.2 mg/kg bm dly. Dos.may be incr.if   resist.to other antimicrob.agents., alone/ in combin.with aminogly-  est., infts.bel.30 days, concom. erythromycin.
   sympts.not adeq.control.but reduc.to min.maint.dos.ASAP.  cos.for endocardit. depend.on causat.organ.  Side effects: GI disturbs.incl.sev./persist.diarrh. dur.or aft.treatm.,
   Toxoplasmos., mycetoma, & suppress.act. on malar plasmo-  Oral admin.of parenter.form for staphylococc. enterocolit. & antibiot.  antibiot.assoc.colit., pseudomembr. colit., hypersens.reacts., abnorm.
   dia: Attain max.dos. of 200 mg dly.more quick.  assoc. pseudomembr.colit. produc.by C.difficile. Oral admin.is not ef-  liv.funct., jaund., hepat.damage., bld.dyscras.
   Side effects: Haemolysis, methaemoglobinaem., agranulocytos.,   fect.for other types of infect.  Special precautions: Atopic pts., GI dis.hist., hepat./ sev.ren.
   aplast.anaem., periph.neuropathy with motor loss, skin rash incl.  (S4) INJ. V/20.1.1/305, Y/20.1.1/164  impairm., discont.treatm.if diarrh. occurs, endoscopy is recomm.
   tox.epiderm. necrolys. & Stev.Johns.syndr., GI disturbs., headache,   774758-008: 500 mg, 10 vials, R921,26  if colit.is suspect
   hepatit., psychos.           794198-008: 1 g, 10 vials, R1 696,78
   Special precautions: Card./pulm.dis., porphyr., sev. anaem., reg.  Dosage: IV: Dly IV dos.2 g.admin 500 mg 6 hrly or 1 g 12 hrly.in   CLINDAMYCIN FRESENIUS AMP, Fresenius Kabi [P/S]
   bld.counts, G6PD defic./ methaemoglob. reduct.pts.more suscept.  0,9 % sod. chlor.IV infus./5 % dextr IV infus. Recomm.conc.5 mg/  Clindamycin.
   to heaemolyt. effs., concom.folic.acid.in pregn. leprosy pts., ex-  ml & in pts.req.fluid restrict. 10 mg/ml may be admin. Admin at   Indications: Suscept.infects.
   cret.in breast milk.         no more than 10 mg/ml. Infus.over at least 60 min./ 500 mg dos.   (S4) INJ. Y/20.1.1/254. 600 mg/4 ml.
   Drug interactions: Probenecid reduc.excret., rifampic.incr.plasma   or 120 min/1 g dos.  701051-003: 10x5 ml amps, R394,66
   clear., incr.dapsone & trimethoprim conc.report.in AIDS pts.  Childr & infts.&gt;1 mnth: 10 mg/kg 4xdly.or 15 mg/ kg 3xdly. Infts.&   Dosage: Discard any unused portion
                                neonates: Init.15 mg/kg then 10 mg/ kg 12 hrly. for neonates in 1st   IM Inj: Adults: Admin.in 2-3-4 div.dos.
                                wk.of life & 8 hrly.thereaft.up to age of 1 mnth. Ref to prod.lit. for   Mod-sev.infects: 600-1 200 mg/day. Sev.infects: 1 200-2 700 mg/day.
                                alternat.dos.scheds.          Childr:
   18.9   Other anti-bacterial   Oral admin: C difficile pseudomembr.colit: Dil.in 30 ml flav.water.   Over 1 mnth.of age: 15-40 mg/kg bm/dly.in div. dos. Sev.infects: Not
                                Adults: 500 mg-2 g in 3-4 div. dos.x7 -10 days. Childr: 40 mg/kg bm
          agents                dly.in 3 -4  div.dos. x7 -10 days not exceed. 2 g  less than 300 mg dly. irrespect. of body mass. Neonates: Safety &
                                                              appropr.dos.in infts.&lt;1 mnth not est.
                                Contraindications: IM inject.
   FIDICID (MDR Listing)        Side effects: Less freq: Neutropen., thrombocytopen., agranulo-  IV infus: Admin.init.dos.as sngl.rapid infus. follow. by contin.IV infus.
                                                              To maint.clindamycin ser.lev: Above 4 µg/ml admin rapid infus.
   TYGACIL (MDR Listing)        cytos., eosinophil., anaphylax., hypersens.react., drug fev., red neck/   rate at 10 mg/ min.x30 mins.with maint.lev.of 0,75 mg/min. Above
   ZYVOXID (MDR Listing)        red man syndr., dizzin., vertigo, hear.loss, deafn., tinnit., card.arrest,   5 µg/ml admin rapid infus.rate at 15 mg/ min.x30 mins.with maint.
   AKLID, (Ascendis) Akacia [P/S]  GI disords.incl. pseudomembr. colit., rash, Stev.-John.syndr., tox.epi-  lev.of 1 mg/min. Above 6 µg/ml admin rapid infus.rate at 20 mg/min.
                                derm. necrolys., vasculit., bull.dermatit., drug rash with eosinophil.
   Linezolid                    & system.sympts., nephrotoxic, ser. creatin./ urea conc.incr., interstit.  x30 mins.with maint.lev.of 1,25 mg/min.
   Indications: Vancomycin-resist.Enterococcus faecium infects., no-  nephrit., ren.fail., pain, tendern., inflammat., necros./ thrombophle-  Since IMI great. than 600 mg not recomm. For IV infus. dil. 300 mg
   socomial/commun.acquir. pneum. caus.by Staphylococcus aureus   bit. at inj.site, fev, chills.  in 50 ml diluent (ie. 6 mg/ml) or more & infus.at follow.rates:
   (methicilllin-suscept.& -resist.strains) or Streptococcus pneumoniae   Warnings and special precautions: Infus.of high. conc.incr.risk   300 mg in 50 ml over 10 min. 600 mg in 100 ml over 20 min. 900 mg
   (incl.multi-med.resist.S pneumoniae strains), complic.skin & skin   of infus.relat.events, rapid bolus admin.may cause exaggerat.hypo-  in 150 ml over 30 min. 1 200 mg in 200 ml over 45 min. Admin.&gt;
   struct. infects. caus.by Staphylococcus aureus (methicilllin-suscept.&   tens.& card. arrest., ototoxic.incl.hear.loss, monit.audit. funct. esp. in   1 200 mg in sngl.1 hr.infus.not recomm. Do not inj.IV as undil.bolus
   -resist.strains)/ Streptococcus pyogenes or Streptococcus agalactiae,   elderly, ren.impairm., elderly, paeds., monit. leukocyte count periodic.  but infus.over 20-60 mins. Suit.dil.are NaCl and dextr.
   uncomplic.skin & skin struct.infects. caus. by Staphylococcus aureus   in prolong.ther./ with concom.meds.caus.neutropen., other concom.   Contraindications: Lincomycin sens., diarrh. states, meningit.,
   (methicilllin-suscept. & -resist.strains) & Streptococcus pyogenes.  neurotox. & nephrotox.drugs, monit.ser.trough lev./ ren. funct.peri-  safety in pregn.& lactat.not est.
   (S4) TABS, 48/20.1.1/0949    odic., safety in pregn.& lactat.not est., consid.pseudomembr.colit.if   Side effects: Diarrh., pseudomembr.colit., N&V, abd. cramps,
   723836-001, 600 mg, 10, R3 830,41  diarrh.develops., safety & effic.of intrathec.admin.not est., poss. te-  taste abnormalit., bld.dyscras., hypersens./ anaphylact.reacts.,
   Dosage: May be taken with/-out food  icoplanin cross-sensitiv., clear.incr.in burn victims, admin.1 hr.bef./4-6   thrombophlebit.
   Adults & adolesc.12 yrs & old:  hrs.aft.cholestyramine     Special precautions: Imp.liv./kidn.funct., other medic. with neuro-
   Commun.acquir.& nosocomial pneum.incl. concurr. bacte-  Interactions: Careful monit.of concur./sequent. system. or topic.  musc.block.activ., monit.organ. syst. functs.in infts.less than 1 mnth.,
   raem: 600 mg 2xdly x 10-14 days.  use of other potent.neurotox./ nephrotox./ototox.drugs., eryth./  reserve for ser. infects.only, GI dis.partic.with colit.hist., porphyr., atop.
   Skin & soft tiss.infect.incl. concurr. bacteraem: 600 mg 2xdly.  infus.-relat. events/ histamine-like flush./anaphylact.reacts. with   pts., superinfect.from prolong. admin.
   x10-14 days.                 concom. anaesthet. meds., neuromusc. block. of suxamethonium &   Drug interactions: Imcompat.with aminophyll./ ampicillin sod./
   Enterococc.infects incl.vancomycin-resist. infects, & those   vecuronium incr., ser.lev. reduc. by dobutamine/dopamine, eff.anat-  barbit./Ca glucon./Mg sulph./ phenytoin sod.& sols.contain.Vit.B Co,
   with concurr.bacteraem: 600 mg 2xdly.x14-28 days.  gonis.by cholestyramine  neuromusc. block.meds.potent., OC effic.reduc., parasympathomim.
   Contraindications: MAOI’s or within 2 wks.of tak. such meds.,   activ.antagon., erythromycin & vit.K antagon.
   pregn.& lactat.not est., concom. SSRIs/SNRIs TCAs/seroton. 5-HT1   CIPLA TEICOPLANIN, Cipla Medpro [P/S]
   recept.agon. (triptans)/ direct& indirect act.sympathomimet. agents/   Teicoplanin.  CUBICIN, MSD [P/S]
   vasopress.agents/dopaminerg.agents/ pethidine or buspirone, uncon-  Indications: Potent.ser.G(+) infects.incl.those that cannot be treat.  Daptomycin
   troll.hypertens./ phaechromocytoma /thyrotoxicos/bipol.depress. /  with other antimicrob., endocardit., septicaem., osteomyelit., resp./  Indications: Complic.skin & skin struct.infects. by suscept.G+ iso-
   schizoaffect.disord./ac.confus.states.  skin & soft tiss. infects., UTI, CAPD assoc.peritonit., prophylax.in or-  lates micro-organ., Staphylococc. aureus bloodstr.infects. (bacte-
   Side effects: Freq: Pseudomembr.colit., oral/vag. candidias., candid-  thopaed./vasc.surg.  raem.) incl.right-sided infect.endocardit.
   iasis, fung.infects., myelosuppress., anaem., leucopen., pancytopen.,   (S4) POWD.FOR SOL.FOR INJ. 43/20.1.1/0611  (S4) POWD.FOR SOL. FOR INFUS. 43/20.1/0954
   thrombocytopen., incr.neutrophils/eosinophils, decr. haemoglob./  721682-001: 400 mg, 3x10 ml vials, R350,18  719869-001-001: 500 mg, sngl.unit, R2 297,88</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page282.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page278.html">278</a>&nbsp;&nbsp;&nbsp;<a href="page279.html">279</a>&nbsp;&nbsp;&nbsp;<a href="page280.html">280</a>&nbsp;&nbsp;&nbsp;<a href="page281.html">281</a>&nbsp;&nbsp;&nbsp;<a href="page282.html">282</a>&nbsp;&nbsp;&nbsp;<a href="page283.html">283</a>&nbsp;&nbsp;&nbsp;<a href="page284.html">284</a>&nbsp;&nbsp;&nbsp;<a href="page285.html">285</a>&nbsp;&nbsp;&nbsp;<a href="page286.html">286</a>&nbsp;&nbsp;&nbsp;<a href="page287.html">287</a>&nbsp;&nbsp;&nbsp;<a href="page288.html">288</a>
             </td>
             <td width="35%"><a href="page284.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page284.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
